$85.94+15.48% · 3M
Moving avg
1W+3.57%
1M+9.66%
3M+15.73%
6M+13.75%
YTD+8.76%
1Y+17.40%
3Y+7.42%
5Y+7.42%
52-week range
$62.3891% of range$88.20
Company health
Value6/6
Growth2/6
Profitability4/6
Health3/6
Dividend0/6
Bull vs bear
Strengths
- Reasonably valued at 9.5x earnings
- Analyst consensus is "Buy"
- High return on equity (3071%)
Risks
- Burning free cash flow
Key statistics
Valuation
Market cap
$14.88B
Enterprise value
$17.96B
P/E ratio (TTM)
9.46x
P/S ratio (TTM)
1.63x
EV/EBITDA
6.52x
Per share & returns
EPS (TTM)
$8.22
Dividend yield
0.00%
Beta (1Y)
0.72
30-day change
+9.66%
Trading
Volume (24h)
240.40K
Previous close
$85.29
Shares outstanding
173.17M
About Solventum Corporation
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Symbol
SOLV
Solventum Corporation is a large-cap healthcare company in the Medical - Instruments & Supplies industry. Its shares are listed on NYSE (United States) and trade under the ticker SOLV.
Frequently asked questions
What is Solventum Corporation's market cap?
Solventum Corporation (SOLV) has a market capitalization of $14.88B.
What is Solventum Corporation's P/E ratio?
Solventum Corporation trades at a price-to-earnings (P/E) ratio of 9.46.
What exchange does SOLV trade on?
SOLV trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,217.61-0.22%
$1.15T cap
Johnson & JohnsonJNJ
$261.48+0.24%
$630.14B cap
AbbVie Inc.ABBV
$250.93+0.87%
$443.33B cap
UnitedHealth Group IncorporatedUNH
$402.36-0.80%
$365.40B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.62+1.28%
$332.49B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap